Teladoc director granted 48,638 RSUs

SALKA SUSAN R reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

SALKA SUSAN R reported acquisition or exercise transactions in this Form 4 filing.

Teladoc Health, Inc. director Susan R. Salka received a grant of 48,638 restricted stock units (RSUs) linked to Teladoc common stock. Each RSU represents a contingent right to receive one share of common stock. One-third of the RSUs vest on the first anniversary of the grant date, with the remaining units vesting in eight substantially equal quarterly installments thereafter. Following this award, Salka directly holds 48,638 RSUs reported in this filing.

Insider Trade Summary

Grant/Award: 48,638 shares

Grant/Award 1 txn

Insider SALKA SUSAN R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	48,638	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 48,638 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
2. F2. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

RSUs granted: 48,638 RSUs Price per RSU: $0.00 Underlying shares: 48,638 shares +3 more

6 metrics

RSUs granted 48,638 RSUs Grant of restricted stock units on March 30, 2026

Price per RSU $0.00 Grant/award acquisition with no exercise price

Underlying shares 48,638 shares Each RSU represents one share of Teladoc common stock

Holdings after grant 48,638 RSUs Total restricted stock units directly held following this award

Initial vesting One-third of RSUs Vests on first anniversary of grant date

Remaining vesting tranches Eight installments Balance vests in eight substantially equal quarterly installments

Key Terms

Restricted Stock Units, contingent right, vest, quarterly installments

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."

vest financial

"One-third of the restricted stock units vest on the first anniversary of the grant date"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

quarterly installments financial

"with the remainder vesting in eight substantially equal quarterly installments thereafter."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Teladoc Health (TDOC) disclose for Susan R. Salka?

Teladoc Health disclosed that director Susan R. Salka received a grant of 48,638 restricted stock units (RSUs). These RSUs are a form of equity compensation that can convert into Teladoc common shares if the vesting conditions are met over time.

How many Teladoc (TDOC) restricted stock units were granted to Susan R. Salka?

Susan R. Salka was granted 48,638 restricted stock units tied to Teladoc common stock. Each unit represents a contingent right to receive one share, giving her potential future ownership that depends on the vesting schedule being satisfied.

What does each Teladoc (TDOC) restricted stock unit represent for Susan R. Salka?

Each restricted stock unit granted to Susan R. Salka represents a contingent right to receive one share of Teladoc common stock. The units only convert into actual shares as they vest according to the time-based vesting schedule disclosed.

What is the vesting schedule for Susan R. Salka’s Teladoc (TDOC) RSU grant?

For Susan R. Salka’s RSU grant, one-third vests on the first anniversary of the grant date. The remaining two-thirds vest in eight substantially equal quarterly installments after that, spreading the vesting over multiple years of board service.

Did Susan R. Salka buy or sell Teladoc (TDOC) shares in this Form 4 filing?

This Form 4 shows an equity grant, not an open-market trade. Susan R. Salka acquired 48,638 restricted stock units as a compensation award, with no reported purchase price and no sales of Teladoc common stock in this filing.

How many Teladoc (TDOC) restricted stock units does Susan R. Salka hold after this grant?

After the reported transaction, Susan R. Salka holds 48,638 restricted stock units directly. These RSUs are derivative interests that can convert into the same number of Teladoc common shares if and as they vest over the stated schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SALKA SUSAN R

(Last) (First) (Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/30/2026		A		48,638		(2)	(2)	Common Stock	48,638	$0	48,638	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

2. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)